PDC*LINE PHARMA
PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.
PDC*LINE PHARMA
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-04-01
Address:
La Tronche, Rhone-Alpes, France
Country:
France
Website Url:
http://www.pdc-line-pharma.com
Total Employee:
1+
Status:
Active
Contact:
+33 (0) 4 84 35 05 04
Total Funding:
41.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Font Awesome Euro Google Maps
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Laurent LEVY Co-Founder & President @ PDC*line Pharma
Co-Founder & President
2014-03-01
Laurent LEVY Co-founder, President France & Chief Operating Officer @ PDC*line Pharma
Co-founder, President France & Chief Operating Officer
2016-06-01
Eric Halioua Chief Executive Officer @ PDC*line Pharma
Chief Executive Officer
2016-06-01
Founder
Investors List
Hansongneotech
Hansongneotech investment in Series B - PDC*line Pharma
Alpha Holdings
Alpha Holdings investment in Series B - PDC*line Pharma
S.R.I.W.
S.R.I.W. investment in Series B - PDC*line Pharma
Korea Investment Partners
Korea Investment Partners investment in Series B - PDC*line Pharma
UTC Investment Co.
UTC Investment Co. investment in Series B - PDC*line Pharma
Brain Asset Management
Brain Asset Management investment in Series B - PDC*line Pharma
SFPI-FPIM
SFPI-FPIM investment in Series B - PDC*line Pharma
Sambrinvest
Sambrinvest investment in Series B - PDC*line Pharma
Meusinvest (Noshaq)
Meusinvest (Noshaq) investment in Series B - PDC*line Pharma
Shinhan-Cognitive Start-up Fund
Shinhan-Cognitive Start-up Fund investment in Series B - PDC*line Pharma
Official Site Inspections
http://www.pdc-line-pharma.com Semrush global rank: 9.33 M Semrush visits lastest month: 174
- Host name: cluster013.ovh.net
- IP address: 213.186.33.24
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "PDC*line Pharma"
About us - PDC*line Pharma
PDC*line Pharma is a clinical-stage Biotechnology company that develops a new class of potent, off-the-shelf therapeutic cancer vaccines based on a proprietary cell line of Plasmacytoid …See details»
PDC*line Pharma - Crunchbase Company Profile
PDC*line Pharma is a clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of …See details»
PDC*line Pharma: Revenue, Worth, Valuation & Competitors 2025
About PDC*line Pharma. PDC*line Pharma is a Biotech related company founded in 2014 and based in France with 40 employees. It has 10 competitors including Dermavant Sciences, …See details»
Securing Strategic Partnerships, Funding and Investment
May 14, 2025 Please can you tell us a little bit about PDC*line Pharma. Founded in 2014 as a spin-off of the French Blood Bank (EFS), PDC*line Pharma is a Belgian-French clinical-stage …See details»
PDC*line Pharma - Lyonbiopôle
Apr 9, 2024 Our organization; Profile of our members; Structural projects; Public funders; Become a member; News & Events ... PDC*line Pharma . Member of Lyonbiopole . Spin-off of …See details»
PDC Line Pharma Company Profile - Office Locations, Competitors …
PDC Line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid …See details»
PDC*Line Pharma
Mar 4, 2020 Based on a robust preclinical package and a first-in-human phase Ib feasibility study in melanoma, PDC*line Pharma is focusing on lung cancer with a new candidate in phase I/II clinical trial (PDC*lung) and neoantigens …See details»
Investors | PDC*line Pharma
In march 2019, PDC*line Pharma granted exclusive license in South Korea and exclusive option in other Asian countriesto LG Chem Life Sciences Company, for the development and …See details»
PDC Line Pharma SASU
PDC*line Pharma presents primary clinical results from phase I/II trial on PDC*lung01 cancer vaccine at ESMO-IO 2024 PDC*lung01, in combination with pembrolizumab, demonstrates the …See details»
PDC*line Pharma - Funding, Financials, Valuation & Investors
PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells. New. Resources. ... How much funding has …See details»
PDC*line Pharma - Crustdata Company Profile, Funding and Growth
PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid …See details»
PDC*line Pharma - Overview, News & Similar companies - ZoomInfo
Jan 17, 2024 PDC*line Pharma contact info: Phone number: +32 42427756 Website: www.pdc-line-pharma.com What does PDC*line Pharma do? Founded in 2014, PDC*line Pharma is a …See details»
Product pipeline - PDC*line Pharma
PDC*line Pharma plans to conduct clinical trials to reach clinical proof of concept by 2024. Partners. R & D. EFS (Etablissement Français du Sang – French Blood Bank) transferred the …See details»
PDC*line Pharma - VentureRadar
Feb 5, 2022 "Founded in April 2014 as a spin-off of the French Blood Bank (Etablissement Français du Sang, EFS), PDC*line Pharma is a Belgian-French biotech company that is …See details»
PDC Line Pharma SA - Drug pipelines, Patents, Clinical trials
Last update 23 Jan 2025. PDC Line Pharma SA. Subsidiary Company |See details»
PDC*line Pharma - Contacts, Employees, Board Members
Organization. PDC*line Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Contacts …See details»
PDC*line Pharma - Company Profile - Tracxn
Feb 22, 2025 PDC*line Pharma - Developer of therapeutic vaccines for the treatment of cancer. Raised a total funding of $61.6M over 10 rounds from 13 investors. Founded by Laurent LEVY …See details»
PDC*line Pharma
PDC*line Pharma is a clinical-stage Biotechnology company that develops a new class of potent, off-the-shelf therapeutic cancer vaccines based on a proprietary cell line of Plasmacytoid …See details»
Technology - PDC*line Pharma
Thanks to its exclusive cell line of Plasmacytoid Dendritic Cells (PDC*line), PDC*line Pharma is offering a groundbreaking solution that addresses the scalability and potency challenges faced …See details»
PDC Line Pharma SASU (PDC Line Pharma SASU) - 药物管线_专利_ …
PDC*line Pharma Unveils New Clinical Results with PDC*lung01 at the European Lung Cancer Congress 2025 March 23rd 2025, PDC*line Pharma is presenting new results from its ongoing …See details»